Metropolitan Life Insurance CO Gritstone Bio, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$1.96 - $2.9 $1,638 - $2,424	836 Added 81.64%	1,860 $4,000
Q4 2023 Feb 14, 2024	SELL	$1.28 - $2.85 $4,883 - $10,872	-3,815 Reduced 78.84%	1,024 $2,000
Q2 2023 Aug 10, 2023	BUY	$1.66 - $3.03 $8,032 - $14,662	4,839 New	4,839 $9,000
Q1 2022 May 12, 2022	SELL	$4.03 - $12.19 $41,968 - $126,946	-10,414 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$8.76 - $13.71 $91,226 - $142,775	10,414 New	10,414 $133,000
Q3 2021 Jun 21, 2023	BUY	$6.41 - $13.54 $66,753 - $141,005	10,414 New	10,414 $112,000
Q3 2021 Mar 30, 2023	SELL	$6.41 - $13.54 $1,506 - $3,181	-235 Reduced 2.21%	10,414 $112,000
Q3 2021 Nov 15, 2021	SELL	$6.41 - $13.54 $1,506 - $3,181	-235 Reduced 2.21%	10,414 $112,000
Q2 2021 Jun 21, 2023	BUY	$8.13 - $10.2 $86,576 - $108,619	10,649 New	10,649 $97,000
Q2 2021 Mar 30, 2023	BUY	$8.13 - $10.2 $24,162 - $30,314	2,972 Added 38.71%	10,649 $97,000
Q2 2021 Aug 16, 2021	BUY	$8.13 - $10.2 $86,511 - $108,538	10,641 Added 133012.5%	10,649 $97,000
Q1 2021 Jun 26, 2023	BUY	$4.07 - $27.11 $31,245 - $208,123	7,677 New	7,677 $72.4 Million
Q1 2021 Mar 30, 2023	SELL	$4.07 - $27.11 $10,700 - $71,272	-2,629 Reduced 25.51%	7,677 $72,000
Q1 2021 May 14, 2021	BUY	$4.07 - $27.11 $32 - $216	8 New	8 $72,000
Q3 2020 Nov 13, 2020	SELL	$2.63 - $8.09 $27,104 - $83,375	-10,306 Closed	0 $0
Q2 2020 Jun 26, 2023	BUY	$5.69 - $8.17 $58,641 - $84,200	10,306 New	10,306 $68,000
Q2 2020 Mar 30, 2023	BUY	$5.69 - $8.17 $6,105 - $8,766	1,073 Added 11.62%	10,306 $68,000
Q2 2020 Aug 14, 2020	BUY	$5.69 - $8.17 $6,105 - $8,766	1,073 Added 11.62%	10,306 $68,000
Q1 2020 Jul 12, 2023	BUY	$5.47 - $11.3 $50,504 - $104,332	9,233 New	9,233 $53,000
Q1 2020 Mar 30, 2023	SELL	$5.47 - $11.3 $2,718 - $5,616	-497 Reduced 5.11%	9,233 $53,000
Q1 2020 May 15, 2020	BUY	$5.47 - $11.3 $50,504 - $104,332	9,233 New	9,233 $54,000
Q4 2019 Feb 14, 2020	SELL	$7.07 - $11.61 $68,791 - $112,965	-9,730 Closed	0 $0
Q3 2019 Jul 12, 2023	BUY	$8.45 - $12.28 $82,218 - $119,484	9,730 New	9,730 $84,000
Q3 2019 Mar 30, 2023	BUY	$8.45 - $12.28 $82,218 - $119,484	9,730 New	9,730 $84,000
Q3 2019 Nov 14, 2019	BUY	$8.45 - $12.28 $82,218 - $119,484	9,730 New	9,730 $84,000
Q2 2019 Jul 12, 2023	BUY	$9.2 - $15.7 $19,522 - $33,315	2,122 New	2,122 $23.6 Million

Others Institutions Holding GRTS

# of Institutions

Shares Held

35.4M

Call Options Held

395K

Put Options Held

132K

View Full List

About Gritstone bio, Inc.

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

More about GRTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account